Product Information

OCTREOTIDE ACET 50 MCG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.6422 per ML under NDC 00641617410. Its NADAC has been published 118 times since May 22, 2024.

FDA first approved this application on Mar 28, 2005. Its Orange Book therapeutic-equivalence code is AP.

OCTREOTIDE ACET 50 MCG/ML VIAL

Octreotide Acetate
$2.6422per ML

Strength

50 ug/mL

NDC

00641617410

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

4/22/2026

Active Ingredients

OCTREOTIDE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076313

FDA Approved

3/28/2005

TE Code

AP

On Market Since

4/4/2005

Pharmacological Classes

Somatostatin Analog
Somatostatin Receptor Agonists

Price Statistics

The NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has been published 118 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$2.6422 per ML
All-time high$2.9314 (Jul 10, 2024)
All-time low$2.2252 (Sep 18, 2024)
52-week high$2.6422
52-week low$2.6216
Median price$2.6216
Average price$2.5922
Largest weekly change-15.2% (Sep 18, 2024)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.8%

3Y

N/A

5Y

N/A

All

-1.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Octreotide Acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OCTREOTIDE ACET 50 MCG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for OCTREOTIDE ACET 50 MCG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.6422 per ML (NDC 00641617410), effective Aug 19, 2026.

How has the price of OCTREOTIDE ACET 50 MCG/ML VIAL changed over time?

Over the history we have for it, the NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for OCTREOTIDE ACET 50 MCG/ML VIAL?

Since May 22, 2024, the NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has ranged from a low of $2.2252 (Sep 18, 2024) to a high of $2.9314 (Jul 10, 2024), with a median of $2.6216 per ML.

Are there cheaper alternatives to OCTREOTIDE ACET 50 MCG/ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of OCTREOTIDE ACET 50 MCG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OCTREOTIDE ACET 50 MCG/ML VIAL?

OCTREOTIDE ACET 50 MCG/ML VIAL (NDC 00641617410) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.